搜索筛选:
搜索耗时1.2166秒,为你在为你在102,285,761篇论文里面共找到 1,000 篇相符的论文内容
类      型:
[会议论文] 作者:Sijin Que,Qiyue Chen,Chaohui Zheng,Ping Li,Changming Huang, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Guangtan Lin,Qiyue Chen,Chaohui Zheng,Changming Huang,Ping Li, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Zening Huang,Qiyue Chen,Ping Li,Chaohui Zheng,Changming Huang, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:li xie,Wenxiao Huang,Junqi Wang,Jie Chen,Xiao Zhou, 来源:2019中国肿瘤学大会 年份:2019
Objective Pterygopalatine and infratemporal fossa(PP-ITF) are relatively small and concealed areas communicating with intracranial and extracranial compartments.The heterogeneity of tissues of the PP-...
[会议论文] 作者:Fan Zhang,Ying Li,Weiran Xu,Liang He,Hong Xu, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Xiao Liu,Yunfeng Fu,Yanwei Luo,Chengyuan Li,Jing Liu, 来源:2019中国肿瘤学大会 年份:2019
Objective Owing to the use of proteasome inhibitor such as bortezomib(BTZ),clinical outcomes of patients with multiple myeloma(MM)have been significantly improved.However,some patients with MM develop...
[会议论文] 作者:Qun Wang,Weijun Lu,Li LU,Tao Yin,Jian Chen, 来源:2019中国肿瘤学大会 年份:2019
Objective Background :BATF2,as an AP-1 inhibitor induced by type I interferon,was first proposed by scholars in 2008 Functional analyses of BATF in cell culture systems and transgenic mice have demons...
[会议论文] 作者:Wenzhi Guo,Li Jie,Zhang Huapeng,Pang Chun,Zhang Shuijun, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Shuijun Zhang,Wenzhi Guo,Jie Li,Huapeng Zhang,Chun Pang, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Xin Ren,Yazhen Qin,Xiaojun Huang,Li Zuo,Qian Jiang, 来源:2019中国肿瘤学大会 年份:2019
Objective Long term tyrosine kinase inhibitors(TKIs)therapy may impact organ function and result in poor treatment outcomes.This study aimed to evaluate the incidence of chronic renal injury in patien...
[会议论文] 作者:Yi Xia,Kuiale Zhao,Yun Chen,Yunhai Li,Feng Xue, 来源:2019中国肿瘤学大会 年份:2019
Objective Oesophageal cancer is highly malignant with a propensity for high rates of local recurrence and metastasis.Although significant advances in staging a nd treatment of patients have recently b...
[会议论文] 作者:Jiawei Lv,Junyan LI,Zixian Wang,Yupei Chen,Ying Sun, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Xiangyi Zheng,Huaqing Yan,Jiangfeng Li,Yufan Yin,Haiyun Xie, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Ying Xing,Ting Wang,Fanglin Tian,Weina Fan,Li Cai, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Cuicui Zhang,Zhen He,Shaomei Li,Xuan Wu,Qiming Wang, 来源:2019中国肿瘤学大会 年份:2019
Objective The current study aims to evaluate the efficacy and safety of etoposide capsules of different doses as maintenance therapy in extensive SCLC patients responded to first line EP/EC treatment....
[会议论文] 作者:LI Qin,ChanJuan Zhang,YanTao Yin,YuXiang Wang,DuanFang Liao, 来源:2019中国肿瘤学大会 年份:2019
Objective Renal cell carcinoma(RCC)has the highest metastasis rate among urological malignancies with unclear mechanisms.Steroid receptor RNA coactivator(SRA)belongs to the long non-coding RNAs(lncRNA...
[会议论文] 作者:Limin Niu,Wei Guo,Xingguo Song,Xianrang Song,Li Xie, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Meiling Xiao,Bicong Yan,Ying Li,Jingjing Lu,Jinwei Qiang, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:tian qiu,Weihua Li,Fanshuang Zhang,Bingning Wang,Jianming Ying, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Chunhai Li,Haipeng Jia,Bo Liu,Hong Meng,Fengmin Pan, 来源:2019中国肿瘤学大会 年份:2019
相关搜索: